07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
24.11.2017
- In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...
22.12.2014
- Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease...
03.07.2014
- Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...
05.05.2014
- Italy is spearheading international efforts to catch a criminal ring that is stealing and recycling sophisticated drugs and reselling them for tens of millions of euros, the...
07.02.2014
- Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...
08.11.2013
- The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...
02.10.2013
- U.S. health regulators expanded the approval of Roche's breast cancer drug Perjeta and will now allow its use to help shrink tumors prior to surgery, the FDA said. The decision...
